{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:08:11Z","timestamp":1791526091708,"version":"4.3.4"},"reference-count":136,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,2,7]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>\n                    Asthma is the most common noncommunicable disease in children, and among the most common in adults. The great majority of people with asthma live in low and middle income countries (LMICs), which have disproportionately high asthma-related morbidity and mortality. Essential inhaled medications, particularly those containing inhaled corticosteroids (ICS), are often unavailable or unaffordable, and this explains much of the global burden of preventable asthma morbidity and mortality. Guidelines developed for LMICs are generally based on the outdated assumption that patients with asthma symptoms &lt;1\u20133 times per week do not need (or benefit from) ICS. Even when ICS are prescribed, many patients manage their asthma with oral or inhaled short-acting \u03b2\n                    <jats:sub>2<\/jats:sub>\n                    -agonists (SABA) alone, owing to issues of availability and affordability. A single ICS\u2013formoterol inhaler-based approach to asthma management for all severities of asthma, from mild to severe, starting at diagnosis, might overcome SABA overuse\/over-reliance and reduce the burden of symptoms and severe exacerbations. However, ICS\u2013formoterol inhalers are currently very poorly available or unaffordable in LMICs. There is a pressing need for pragmatic clinical trial evidence of the feasibility and cost-effectiveness of this and other strategies to improve asthma care in these countries. The global health inequality in asthma care that deprives so many children, adolescents and adults of healthy lives and puts them at increased risk of death, despite the availability of highly effective therapeutic approaches, is unacceptable. A World Health Assembly Resolution on universal access to affordable and effective asthma care is needed to focus attention and investment on addressing this need.\n                  <\/jats:p>","DOI":"10.1183\/13993003.03179-2021","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T12:36:54Z","timestamp":1645706214000},"page":"2103179","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":153,"title":["Asthma management in low and middle income countries: case for change"],"prefix":"10.1183","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8118-8871","authenticated-orcid":false,"given":"Kevin","family":"Mortimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6695-6350","authenticated-orcid":false,"given":"Helen K.","family":"Reddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7319-1133","authenticated-orcid":false,"given":"Paulo M.","family":"Pitrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-5849","authenticated-orcid":false,"given":"Eric D.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"2026061109251598000_60.3.2103179.1","unstructured":"Global Asthma Network . The Global Asthma Report 2018. Auckland, Global Asthma Network, 2018."},{"key":"2026061109251598000_60.3.2103179.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01450-1"},{"key":"2026061109251598000_60.3.2103179.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02865-2021"},{"key":"2026061109251598000_60.3.2103179.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02866-2021"},{"key":"2026061109251598000_60.3.2103179.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"2026061109251598000_60.3.2103179.6","unstructured":"Global Burden of Disease Collaborative Network . Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, Institute for Health Metrics and Evaluation (IHME), 2020. https:\/\/ghdx.healthdata.org\/gbd-results-tool"},{"key":"2026061109251598000_60.3.2103179.7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(21)00458-X","article-title":"Improving lung health in low-income and middle-income countries: from challenges to solutions","volume":"397","author":"Meghji","year":"2021","journal-title":"Lancet"},{"key":"2026061109251598000_60.3.2103179.8","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/all.12237","article-title":"Level of asthma control and healthcare utilization in Latin America","volume":"68","author":"Gold","year":"2013","journal-title":"Allergy"},{"key":"2026061109251598000_60.3.2103179.9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/17476348.2019.1651201","article-title":"Asthma management and control in Nigeria: the asthma insight and reality Nigeria (AIRNIG) study","volume":"13","author":"Ozoh","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"2026061109251598000_60.3.2103179.10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/02770903.2018.1445267","article-title":"Respira project: humanistic and economic burden of asthma in Brazil","volume":"56","author":"Can\u00e7ado","year":"2019","journal-title":"J Asthma"},{"key":"2026061109251598000_60.3.2103179.11","unstructured":"Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2021. Available from: http:\/\/ginasthma.org\/"},{"key":"2026061109251598000_60.3.2103179.12","unstructured":"World Bank . The World by Income and Region. 2020. https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html Date last accessed: October 2021."},{"key":"2026061109251598000_60.3.2103179.13","unstructured":"World Bank . World Bank Country and Lending Groups. 2021. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups Date last accessed: October 2021."},{"key":"2026061109251598000_60.3.2103179.14","unstructured":"Institute for Health Metrics and Evaluation . Asthma - Level 3 Cause. 2020. www.healthdata.org\/results\/gbd_summaries\/2019\/asthma-level-3-cause Date last accessed: October 2021."},{"key":"2026061109251598000_60.3.2103179.15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-2196"},{"key":"2026061109251598000_60.3.2103179.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00156-7"},{"key":"2026061109251598000_60.3.2103179.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.01.013"},{"key":"2026061109251598000_60.3.2103179.18","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2012-303043"},{"key":"2026061109251598000_60.3.2103179.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2010.03691.x"},{"key":"2026061109251598000_60.3.2103179.20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1146"},{"key":"2026061109251598000_60.3.2103179.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.09.049"},{"key":"2026061109251598000_60.3.2103179.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.03.037"},{"key":"2026061109251598000_60.3.2103179.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.06.038"},{"key":"2026061109251598000_60.3.2103179.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047526"},{"key":"2026061109251598000_60.3.2103179.25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-0439"},{"key":"2026061109251598000_60.3.2103179.26","doi-asserted-by":"crossref","first-page":"e12532","DOI":"10.1111\/ijpo.12532","article-title":"Association between overweight or obesity and the risk for childhood asthma and wheeze: an updated meta-analysis on 18 articles and 73 252 children","volume":"14","author":"Deng","year":"2019","journal-title":"Pediatr Obes"},{"key":"2026061109251598000_60.3.2103179.27","doi-asserted-by":"publisher","DOI":"10.1111\/all.12561"},{"key":"2026061109251598000_60.3.2103179.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2016.11.012"},{"key":"2026061109251598000_60.3.2103179.29","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/S2542-5196(19)30046-4","article-title":"Global, national, and urban burdens of paediatric asthma incidence attributable to ambient NO2 pollution: estimates from global datasets","volume":"3","author":"Achakulwisut","year":"2019","journal-title":"Lancet Planet Health"},{"key":"2026061109251598000_60.3.2103179.30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.envres.2017.08.038","article-title":"The impact of prenatal exposure to air pollution on childhood wheezing and asthma: a systematic review","volume":"159","author":"Hehua","year":"2017","journal-title":"Environ Res"},{"key":"2026061109251598000_60.3.2103179.31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201405-0901PP"},{"key":"2026061109251598000_60.3.2103179.32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/all.12800","article-title":"Asthma and dietary intake: an overview of systematic reviews","volume":"71","author":"Garcia-Larsen","year":"2016","journal-title":"Allergy"},{"key":"2026061109251598000_60.3.2103179.33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/nu9040341","article-title":"Effects of fruit and vegetable consumption on risk of asthma, wheezing and immune responses: a systematic review and meta-analysis","volume":"9","author":"Hosseini","year":"2017","journal-title":"Nutrients"},{"key":"2026061109251598000_60.3.2103179.34","first-page":"68","article-title":"Dietary strategies for primary prevention of atopic diseases - what do we know?","volume":"20","author":"Lis-Swiety","year":"2016","journal-title":"Dev Period Med"},{"key":"2026061109251598000_60.3.2103179.35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/02770903.2014.952435","article-title":"Is elective cesarean section associated with a higher risk of asthma? A meta-analysis","volume":"52","author":"Huang","year":"2015","journal-title":"J Asthma"},{"key":"2026061109251598000_60.3.2103179.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2010.03665.x"},{"key":"2026061109251598000_60.3.2103179.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2012.04002.x"},{"key":"2026061109251598000_60.3.2103179.38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.iac.2019.03.009","article-title":"Helminths and asthma: risk and protection","volume":"39","author":"Fernandes","year":"2019","journal-title":"Immunol Allergy Clin North Am"},{"key":"2026061109251598000_60.3.2103179.39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/MOP.0000000000000419","article-title":"The microbiome in asthma","volume":"28","author":"Rivas","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"2026061109251598000_60.3.2103179.40","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/ppul.23795","article-title":"The role of respiratory tract infections and the microbiome in the development of asthma: a narrative review","volume":"52","author":"van Meel","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"2026061109251598000_60.3.2103179.41","unstructured":"World Health Organization . WHO Global Report on Trends in Prevalence of Tobacco Smoking 2000\u20132025 . 2nd Edn. Geneva, WHO, 2018. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272694\/9789241514170-eng.pdf"},{"key":"2026061109251598000_60.3.2103179.42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042843"},{"key":"2026061109251598000_60.3.2103179.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69283-0"},{"key":"2026061109251598000_60.3.2103179.44","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.106609"},{"key":"2026061109251598000_60.3.2103179.45","doi-asserted-by":"crossref","unstructured":"Stolbrink M , Thomson H , Hadfield RM , et al . The availability, cost and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review. SSRN 2022; preprint [https:\/\/doi.org\/10.2139\/ssrn.4023200].","DOI":"10.2139\/ssrn.4023200"},{"key":"2026061109251598000_60.3.2103179.46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5644\/ama2006-124.296","article-title":"Childhood asthma: low and middle-income countries perspective","volume":"49","author":"Soto-Mart\u00ednez","year":"2020","journal-title":"Acta Med Acad"},{"key":"2026061109251598000_60.3.2103179.47","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.3.175"},{"key":"2026061109251598000_60.3.2103179.48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1099-0496(199910)28:4<297::AID-PPUL9>3.0.CO;2-S","article-title":"Cultural barriers to asthma management","volume":"28","author":"Enarson","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"2026061109251598000_60.3.2103179.49","first-page":"353","article-title":"Challenges in treating pediatric asthma in developing countries","volume":"14","author":"Zar","year":"2012","journal-title":"Paediatr Drugs"},{"key":"2026061109251598000_60.3.2103179.50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/1471-2458-14-403","article-title":"A systematic review of explanatory factors of barriers and facilitators to improving asthma management in South Asian children","volume":"14","author":"Lakhanpaul","year":"2014","journal-title":"BMC Public Health"},{"key":"2026061109251598000_60.3.2103179.51","doi-asserted-by":"publisher","DOI":"10.1136\/tc.2010.038786"},{"key":"2026061109251598000_60.3.2103179.52","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/add.14518","article-title":"The efficacy of smoking cessation interventions in low- and middle-income countries: a systematic review and meta-analysis","volume":"114","author":"Akanbi","year":"2019","journal-title":"Addiction"},{"key":"2026061109251598000_60.3.2103179.53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/ijerph16010062","article-title":"Dealing with access to spirometry in Africa: a commentary on challenges and solutions","volume":"16","author":"Masekela","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"2026061109251598000_60.3.2103179.54","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00572-2020"},{"key":"2026061109251598000_60.3.2103179.55","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201804-0682CI"},{"key":"2026061109251598000_60.3.2103179.56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19627"},{"key":"2026061109251598000_60.3.2103179.57","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00002612"},{"key":"2026061109251598000_60.3.2103179.58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2009.02455.x"},{"key":"2026061109251598000_60.3.2103179.59","unstructured":"World Health Organization . WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care. Geneva, WHO, 2020. www.who.int\/publications\/i\/item\/who-package-of-essential-noncommunicable-(pen)-disease-interventions-for-primary-health-care"},{"key":"2026061109251598000_60.3.2103179.60","unstructured":"World Health Organization . Implementation Tools. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva, WHO, 2013. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/133525\/%039789241506557_eng.pdf?sequence=1"},{"issue":"Suppl. 1","key":"2026061109251598000_60.3.2103179.61","first-page":"7","article-title":"Integrated management of childhood illness by outpatient health workers: technical basis and overview. The WHO Working Group on Guidelines for Integrated Management of the Sick Child","volume":"75","author":"Gove","year":"1997","journal-title":"Bull World Health Organ"},{"key":"2026061109251598000_60.3.2103179.62","unstructured":"World Health Organization Department of Child and Adolescent Health and Development, UNICEF . Handbook IMCI Integrated Management of Childhood Illness. Geneva, WHO, 2005."},{"key":"2026061109251598000_60.3.2103179.63","first-page":"582","article-title":"Integrated management of childhood illness: a summary of first experiences","volume":"77","author":"Lambrechts","year":"1999","journal-title":"Bull World Health Organ"},{"key":"2026061109251598000_60.3.2103179.64","unstructured":"World Health Organization . IMAI District Clinician Manual: Hospital Care Adolescents and Adults: Guidelines for the Management of Illnesses with Limited-Resources. Geneva, WHO, 2012. https:\/\/apps.who.int\/iris\/handle\/10665\/77751"},{"key":"2026061109251598000_60.3.2103179.65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-000962"},{"key":"2026061109251598000_60.3.2103179.66","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001921"},{"key":"2026061109251598000_60.3.2103179.67","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.5588\/ijtld.20.0172","article-title":"A comparative analysis of asthma treatment guidelines and Essential Medicine Lists in sub-Saharan Africa","volume":"24","author":"Siduna","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026061109251598000_60.3.2103179.68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008033430504"},{"key":"2026061109251598000_60.3.2103179.69","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.10.880"},{"key":"2026061109251598000_60.3.2103179.70","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12891-7"},{"key":"2026061109251598000_60.3.2103179.71","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00076604"},{"key":"2026061109251598000_60.3.2103179.72","unstructured":"M\u00e9decins Sans Fronti\u00e8res. Clinical Guidelines - Diagnosis and Treatment Manual. 2021. https:\/\/medicalguidelines.msf.org\/viewport\/CG\/english\/clinical-guidelines-16686604.html"},{"key":"2026061109251598000_60.3.2103179.73","unstructured":"Global Asthma Network . Asthma Management Guidelines. http:\/\/globalasthmanetwork.org\/management\/management.php Date last accessed: October 2021."},{"key":"2026061109251598000_60.3.2103179.74","unstructured":"A\u00eft-Khaled N , Enarson DA , Chiang C-Y , et al. Management of Asthma. A Guide to the Essentials of Good Clinical Practice. 3rd Edn. Paris, International Union Against Tuberculosis and Lung Disease, 2008."},{"key":"2026061109251598000_60.3.2103179.75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01046-2019"},{"key":"2026061109251598000_60.3.2103179.76","doi-asserted-by":"crossref","first-page":"2102730","DOI":"10.1183\/13993003.02730-2021","article-title":"Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes","volume":"59","author":"Reddel","year":"2022","journal-title":"Eur Respir J"},{"issue":"Suppl. 10","key":"2026061109251598000_60.3.2103179.77","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1753-6561-9-S10-S3","article-title":"Improving access to effective care for people with chronic respiratory symptoms in low and middle income countries","volume":"9","author":"Mortimer","year":"2015","journal-title":"BMC Proc"},{"key":"2026061109251598000_60.3.2103179.78","unstructured":"World Health Organization . WHO Technical Consultation on Oxygen Access Scale-Up for COVID-19. Geneva, WHO, 2021. www.who.int\/publications\/i\/item\/9789240031517"},{"key":"2026061109251598000_60.3.2103179.79","unstructured":"International Union Against Tuberculosis and Lung Disease . International Union Against Tuberculosis and Lung Disease Strategic Plan for Lung Health 2020\u20132025. https:\/\/theunion.org\/our-work\/lung-health-ncds\/asthma Date last accessed: October 2021."},{"key":"2026061109251598000_60.3.2103179.80","doi-asserted-by":"crossref","unstructured":"World Health Organization . WHO Model List of Essential Medicines \u2013 22nd list, 2021. Geneva, WHO, 2021. www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2021.02","DOI":"10.1530\/ey.19.13.1"},{"key":"2026061109251598000_60.3.2103179.81","doi-asserted-by":"crossref","unstructured":"World Health Organization . WHO Model List of Essential Medicines for Children \u2013 8th list, 2021. Geneva, WHO, 2021. www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2021.03","DOI":"10.1530\/ey.19.13.1"},{"key":"2026061109251598000_60.3.2103179.82","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.2002.01056.x"},{"key":"2026061109251598000_60.3.2103179.83","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.115653"},{"key":"2026061109251598000_60.3.2103179.84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.rmed.2016.10.008","article-title":"Free asthma medications reduces hospital admissions in Brazil (Free asthma drugs reduces hospitalizations in Brazil)","volume":"121","author":"Comaru","year":"2016","journal-title":"Respir Med"},{"key":"2026061109251598000_60.3.2103179.85","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1415"},{"key":"2026061109251598000_60.3.2103179.86","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/JAA.S176026","article-title":"Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study","volume":"11","author":"Price","year":"2018","journal-title":"J Asthma Allergy"},{"key":"2026061109251598000_60.3.2103179.87","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s40273-013-0095-9","article-title":"The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries","volume":"31","author":"Babar","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"2026061109251598000_60.3.2103179.88","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.20.0762"},{"key":"2026061109251598000_60.3.2103179.89","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13497"},{"key":"2026061109251598000_60.3.2103179.90","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13223-019-0329-2","article-title":"Availability and affordability of medicines and diagnostic tests recommended for management of asthma and chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review","volume":"15","author":"Kibirige","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2026061109251598000_60.3.2103179.91","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1208\/s12248-015-9787-8","article-title":"Regulatory considerations for approval of generic inhalation drug products in the US, EU, Brazil, China, and India","volume":"17","author":"Lee","year":"2015","journal-title":"AAPS J"},{"key":"2026061109251598000_60.3.2103179.92","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049505"},{"key":"2026061109251598000_60.3.2103179.93","unstructured":"World Health Organization . Global COVID-19 Vaccination \u2013 Strategic Vision for 2022. Technical Document. 2021. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/sage\/covid\/global-covid-19-vaccination-strategic-vision-for-2022_sage-yellow-book.pdf"},{"key":"2026061109251598000_60.3.2103179.94","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00101009"},{"key":"2026061109251598000_60.3.2103179.95","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1590\/S1806-37132008000900002","article-title":"Reduction in the number of asthma-related hospital admissions after the implementation of a multidisciplinary asthma control program in the city of Londrina, Brazil","volume":"34","author":"Cerci Neto","year":"2008","journal-title":"J Bras Pneumol"},{"key":"2026061109251598000_60.3.2103179.96","first-page":"911","article-title":"Treatment outcome of asthma after one year follow-up in health centres of several developing countries","volume":"10","author":"A\u00eft-Khaled","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026061109251598000_60.3.2103179.97","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2471\/BLT.20.271239","article-title":"Addressing barriers to primary health-care services for noncommunicable diseases in the African Region","volume":"98","author":"Tesema","year":"2020","journal-title":"Bull World Health Organ"},{"key":"2026061109251598000_60.3.2103179.98","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001124"},{"key":"2026061109251598000_60.3.2103179.99","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001108"},{"key":"2026061109251598000_60.3.2103179.100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/s12913-020-05201-w","article-title":"Addressing the quality and scope of paediatric primary care in South Africa: evaluating contextual impacts of the introduction of the Practical Approach to Care Kit for children (PACK Child)","volume":"20","author":"Murdoch","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2026061109251598000_60.3.2103179.101","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001088"},{"key":"2026061109251598000_60.3.2103179.102","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-000957"},{"key":"2026061109251598000_60.3.2103179.103","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/WOX.0b013e3181dc3383","article-title":"The impact of a program for control of asthma in a low-income setting","volume":"3","author":"Cruz","year":"2010","journal-title":"World Allergy Organ J"},{"key":"2026061109251598000_60.3.2103179.104","first-page":"4992","article-title":"Successful implementation of asthma guidelines in Thailand: the Easy Asthma Clinic model","volume":"38","author":"Boonsawat","year":"2014","journal-title":"Eur Respir J"},{"key":"2026061109251598000_60.3.2103179.105","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaci.2016.12.001","article-title":"The Finnish experience to save asthma costs by improving care in 1987\u20132013","volume":"139","author":"Haahtela","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2026061109251598000_60.3.2103179.106","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-2600(19)30030-X","article-title":"Asthma control: learning from Finland's success","volume":"7","author":"Burki","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026061109251598000_60.3.2103179.107","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-6-22"},{"key":"2026061109251598000_60.3.2103179.108","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01872-2019"},{"key":"2026061109251598000_60.3.2103179.109","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.2018.2769","article-title":"Association of inhaled corticosteroids and long-acting \u03b2-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"key":"2026061109251598000_60.3.2103179.110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007313.pub3"},{"key":"2026061109251598000_60.3.2103179.111","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.rmed.2009.07.018","article-title":"Budesonide\/formoterol maintenance and reliever therapy versus conventional best practice","volume":"103","author":"Demoly","year":"2009","journal-title":"Respir Med"},{"key":"2026061109251598000_60.3.2103179.112","first-page":"CD013518","article-title":"Combination fixed-dose \u03b2 agonist and steroid inhaler as required for adults or children with mild asthma","volume":"5","author":"Crossingham","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026061109251598000_60.3.2103179.113","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901963"},{"key":"2026061109251598000_60.3.2103179.114","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31948-8"},{"key":"2026061109251598000_60.3.2103179.115","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203557"},{"key":"2026061109251598000_60.3.2103179.116","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp08X263802"},{"key":"2026061109251598000_60.3.2103179.117","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69284-2"},{"key":"2026061109251598000_60.3.2103179.118","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-2600(20)30416-1","article-title":"Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study","volume":"9","author":"O'Byrne","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026061109251598000_60.3.2103179.119","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.07.014"},{"key":"2026061109251598000_60.3.2103179.120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1465-9921-13-59","article-title":"The effect of budesonide\/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy","volume":"13","author":"Buhl","year":"2012","journal-title":"Respir Res"},{"key":"2026061109251598000_60.3.2103179.121","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715274"},{"key":"2026061109251598000_60.3.2103179.122","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715275"},{"key":"2026061109251598000_60.3.2103179.123","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s12890-021-01775-1","article-title":"Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma","volume":"21","author":"Buend\u00eda","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2026061109251598000_60.3.2103179.124","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063861"},{"key":"2026061109251598000_60.3.2103179.125","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.10893"},{"key":"2026061109251598000_60.3.2103179.126","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62145-9"},{"key":"2026061109251598000_60.3.2103179.127","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaip.2019.06.030","article-title":"A pragmatic trial of symptom-based inhaled corticosteroid use in African-American children with mild asthma","volume":"8","author":"Sumino","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026061109251598000_60.3.2103179.128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S2213-2600(18)30513-7","article-title":"Calling time on asthma deaths in tropical regions-how much longer must people wait for essential medicines?","volume":"7","author":"Asher","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026061109251598000_60.3.2103179.129","unstructured":"World Health Organization . New WHA Resolution to Bring Much Needed Boost to Diabetes Prevention and Control Efforts. 2021 . www.who.int\/news\/item\/27-05-2021-new-wha-resolution-to-bring-much-needed-boost-to-diabetes-prevention-and-control-efforts Date last accessed: December 2021."},{"key":"2026061109251598000_60.3.2103179.130","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/jcpt.13126","article-title":"Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: a systematic review and meta-analysis","volume":"45","author":"Jia","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"2026061109251598000_60.3.2103179.131","doi-asserted-by":"crossref","first-page":"106154","DOI":"10.1016\/j.rmed.2020.106154","article-title":"Patient experiences of as-needed budesonide-formoterol by Turbuhaler for treatment of mild asthma; a qualitative study","volume":"175","author":"Foster","year":"2020","journal-title":"Respir Med"},{"key":"2026061109251598000_60.3.2103179.132","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214343"},{"key":"2026061109251598000_60.3.2103179.133","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02073-2019"},{"key":"2026061109251598000_60.3.2103179.134","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(13)70012-2","article-title":"Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial","volume":"1","author":"Papi","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026061109251598000_60.3.2103179.135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1465-9921-12-38","article-title":"Overall asthma control achieved with budesonide\/formoterol maintenance and reliever therapy for patients on different treatment steps","volume":"12","author":"Bateman","year":"2011","journal-title":"Respir Res"},{"key":"2026061109251598000_60.3.2103179.136","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01688-2017"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.03179-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:25:34Z","timestamp":1781195134000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.03179-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":136,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9,15]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1183\/13993003.03179-2021"],"URL":"https:\/\/doi.org\/10.1183\/13993003.03179-2021","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]}}}